Table 2.
Group | 1 day | 2 day | 3 day | 4 day | 5 day | 6 day | 7 day |
---|---|---|---|---|---|---|---|
Normal | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
4 | 0 | 0 | 0 | 0 | 0 | ||
Model | 3/20 | 4/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
LcS | 3/20 | 3/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
Geniposide | 1/20 | 2/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
Dexamethasone | 1/20 | 1/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
LcS+geniposide | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 | 0/20 |
Normal: untreated mice; model: mice with induced sepsis; Lactobacillus casei strain Shirota (LcS): 5 × 107 colony-forming unit (CFU)/kg-treated mice with sepsis; geniposide: 50 mg/kg geniposide-treated mice with sepsis; dexamethasone: 1 mg/kg dexamethasone-treated mice with sepsis; LcS + geniposide: 5 × 107 CFU/kg LcS and 50 mg/kg geniposide-treated mice with sepsis.